Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
biote Corp. reported the fourth quarter ended December 31, 2023 results: revenue $45.7 million, net income $12.1 million, EPS $0.18. Guidance reaffirmed.
- Period
- the fourth quarter ended December 31, 2023
- Revenue
- $45.7 million
- Net income
- $12.1 million
- EPS
- $0.18
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights (All financial result comparisons made are against the prior-year period) • Revenue of $45.7 million, a 2.7% increase and in line with pre-released financial guidance • Procedure revenue of $34.9 million, up 6.6% • Gross profit margin of 69.4%, a more than 400-basis point
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
biote Corp. reported the full year ended December 31, 2023 results: revenue $185.4 million, net income $(2.8) million, EPS $0.13 per diluted share. Guidance reaffirmed.
- Period
- the full year ended December 31, 2023
- Revenue
- $185.4 million
- Net income
- $(2.8) million
- EPS
- $0.13 per diluted share
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
financial guidance • Adjusted EBITDA margin 1 of 29.7% Full Year 2023 Financial Highlights (All financial result comparisons made are against the prior year) • Revenue of $185.4 million, a 12.4% increase • Procedure revenue of $141.0 million, up 9.3% • Gross profit margin of 68.8%, an approximately 190-basis point increase • Net loss of $(2.8) million,
View on SEC.gov